U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07934264) titled '[18F]ZDG2 First-in-Human PET Imaging in PAH' on Sept. 29.
Brief Summary: The goal of this study is to find out whether [18F]ZDG2 can detect early blood vessel changes in people with pulmonary arterial hypertension (PAH). The study will help answer this question:
Can a positron emission tomography (PET) scan using [18F]ZDG2 help identify PAH?
Participants will:
* Receive one or two doses of the study tracer [18F]ZDG2 and have a PET/CT scan after each dose
* Provide blood and urine samples
* Tell the study team about any side effects or symptoms you experience
Study Start Date: Nov. 14
Study Type: INTERVENTIONAL
Condition:
Pu...